February 2012 Briefing - HIV & AIDSLast Updated: March 01, 2012.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for February 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Despite Benefits of Selenium, Supplements May Be Harmful
WEDNESDAY, Feb. 29 (HealthDay News) -- While selenium is necessary for good health, levels that are too high can be harmful, and people whose serum selenium levels are already at least 122 µ/L should not take supplements, according to a review published online Feb. 29 in The Lancet.
High Levels of Genital HLA-G Linked With HIV-1 Infection
THURSDAY, Feb. 16 (HealthDay News) -- High genital levels of soluble HLA-G (sHLA-G), a powerful modulator of the immune response, are associated with HIV-1 infection in Beninese commercial sex workers (CSWs), according to a study published online in PLoS One.
Cash Transfers Help Reduce HIV Infection in African Girls
WEDNESDAY, Feb. 15 (HealthDay News) -- Financially empowering school-aged girls in Africa may reduce the likelihood of infection by HIV and herpes simplex virus 2 (HSV-2), according to a study published online Feb. 15 in The Lancet.
Big Waistline in HIV Tied to Neurocognitive Impairment
MONDAY, Feb. 13 (HealthDay News) -- Central obesity is linked to an increased risk of decreased mental functioning in HIV-positive individuals, according to a study published in the Feb. 14 issue of Neurology.
|Previous: February 2012 Briefing - Gastroenterology||Next: February 2012 Briefing - Infectious Disease|
Reader comments on this article are listed below. Review our comments policy.